Design of cyclized selective melanotropins

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

This article describes the development of cyclic peptides for G-protein coupled receptors to enable structure-function knowledge and the design of novel therapeutics. One important property of cyclic peptides is that they tend to be resistant to the digestion, enabling them to survive in the human digestive tract. This trait makes them very important as drug leads or as scaffolds which, in theory, can be engineered to incorporate a peptide domain of medicinal value. This is especially important for delivery of peptides that would be destroyed without such implementation. The melanocortin system is the focus of this article, and includes melanotropin ligands and melanocortin receptors. We examine two strategies to constrain the melanotropin peptide backbone. The first is based on global constraint of peptides by cyclization using various kinds of linkers. In the second approach we describe the use of a natural cyclized template, the cyclotide, to graft the melanotropin phamacophore, -His-Phe-Arg-Trp-, to obtain selective drug leads. In these examples the conserved melanocyte stimulating hormone pharmacophore is examined and the modified peptides were synthesized by solid phase methodology. Biological studies confirmed the production of selective, potent and in some cases orally available ligands.

Original languageEnglish (US)
Pages (from-to)876-883
Number of pages8
JournalBiopolymers
Volume106
Issue number6
DOIs
StatePublished - Nov 1 2016

Fingerprint

Melanocyte-Stimulating Hormones
Peptides
Cyclic Peptides
Cyclotides
Melanocortin Receptors
Melanocortins
Ligands
Cyclization
G-Protein-Coupled Receptors
Pharmaceutical Preparations
Hormones
Gastrointestinal Tract
Digestion
Grafts
Scaffolds
Transplants
Proteins

Keywords

  • cyclized peptide
  • cyclotide
  • G-protein coupled receptors
  • melanocortin system
  • melanotropin
  • selectivity

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Biomaterials
  • Organic Chemistry

Cite this

Design of cyclized selective melanotropins. / Cai, Minying; Hruby, Victor J.

In: Biopolymers, Vol. 106, No. 6, 01.11.2016, p. 876-883.

Research output: Contribution to journalReview article

@article{353350c15b74445c92daa70e4791dddb,
title = "Design of cyclized selective melanotropins",
abstract = "This article describes the development of cyclic peptides for G-protein coupled receptors to enable structure-function knowledge and the design of novel therapeutics. One important property of cyclic peptides is that they tend to be resistant to the digestion, enabling them to survive in the human digestive tract. This trait makes them very important as drug leads or as scaffolds which, in theory, can be engineered to incorporate a peptide domain of medicinal value. This is especially important for delivery of peptides that would be destroyed without such implementation. The melanocortin system is the focus of this article, and includes melanotropin ligands and melanocortin receptors. We examine two strategies to constrain the melanotropin peptide backbone. The first is based on global constraint of peptides by cyclization using various kinds of linkers. In the second approach we describe the use of a natural cyclized template, the cyclotide, to graft the melanotropin phamacophore, -His-Phe-Arg-Trp-, to obtain selective drug leads. In these examples the conserved melanocyte stimulating hormone pharmacophore is examined and the modified peptides were synthesized by solid phase methodology. Biological studies confirmed the production of selective, potent and in some cases orally available ligands.",
keywords = "cyclized peptide, cyclotide, G-protein coupled receptors, melanocortin system, melanotropin, selectivity",
author = "Minying Cai and Hruby, {Victor J}",
year = "2016",
month = "11",
day = "1",
doi = "10.1002/bip.22976",
language = "English (US)",
volume = "106",
pages = "876--883",
journal = "Biopolymers",
issn = "0006-3525",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Design of cyclized selective melanotropins

AU - Cai, Minying

AU - Hruby, Victor J

PY - 2016/11/1

Y1 - 2016/11/1

N2 - This article describes the development of cyclic peptides for G-protein coupled receptors to enable structure-function knowledge and the design of novel therapeutics. One important property of cyclic peptides is that they tend to be resistant to the digestion, enabling them to survive in the human digestive tract. This trait makes them very important as drug leads or as scaffolds which, in theory, can be engineered to incorporate a peptide domain of medicinal value. This is especially important for delivery of peptides that would be destroyed without such implementation. The melanocortin system is the focus of this article, and includes melanotropin ligands and melanocortin receptors. We examine two strategies to constrain the melanotropin peptide backbone. The first is based on global constraint of peptides by cyclization using various kinds of linkers. In the second approach we describe the use of a natural cyclized template, the cyclotide, to graft the melanotropin phamacophore, -His-Phe-Arg-Trp-, to obtain selective drug leads. In these examples the conserved melanocyte stimulating hormone pharmacophore is examined and the modified peptides were synthesized by solid phase methodology. Biological studies confirmed the production of selective, potent and in some cases orally available ligands.

AB - This article describes the development of cyclic peptides for G-protein coupled receptors to enable structure-function knowledge and the design of novel therapeutics. One important property of cyclic peptides is that they tend to be resistant to the digestion, enabling them to survive in the human digestive tract. This trait makes them very important as drug leads or as scaffolds which, in theory, can be engineered to incorporate a peptide domain of medicinal value. This is especially important for delivery of peptides that would be destroyed without such implementation. The melanocortin system is the focus of this article, and includes melanotropin ligands and melanocortin receptors. We examine two strategies to constrain the melanotropin peptide backbone. The first is based on global constraint of peptides by cyclization using various kinds of linkers. In the second approach we describe the use of a natural cyclized template, the cyclotide, to graft the melanotropin phamacophore, -His-Phe-Arg-Trp-, to obtain selective drug leads. In these examples the conserved melanocyte stimulating hormone pharmacophore is examined and the modified peptides were synthesized by solid phase methodology. Biological studies confirmed the production of selective, potent and in some cases orally available ligands.

KW - cyclized peptide

KW - cyclotide

KW - G-protein coupled receptors

KW - melanocortin system

KW - melanotropin

KW - selectivity

UR - http://www.scopus.com/inward/record.url?scp=84996561930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996561930&partnerID=8YFLogxK

U2 - 10.1002/bip.22976

DO - 10.1002/bip.22976

M3 - Review article

VL - 106

SP - 876

EP - 883

JO - Biopolymers

JF - Biopolymers

SN - 0006-3525

IS - 6

ER -